Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

HCW Biologics (HCWB) Short Interest Ratio & Short Volume

HCW Biologics logo
$3.45 +0.14 (+4.23%)
Closing price 03:59 PM Eastern
Extended Trading
$3.46 +0.01 (+0.43%)
As of 06:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

HCW Biologics Short Interest Data

HCW Biologics (HCWB) has a short interest of 77,800 shares, representing 4.25% of the float (the number of shares available for trading by the public). This marks a 49.90% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 31,502 shares to cover all short positions.

Current Short Interest
77,800 shares
Previous Short Interest
51,900 shares
Change Vs. Previous Month
+49.90%
Dollar Volume Sold Short
$329.87 thousand
Short Interest Ratio
0.1 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
2,150,000 shares
Float Size
1,830,000 shares
Short Percent of Float
4.25%
Today's Trading Volume
16,833 shares
Average Trading Volume
31,502 shares
Today's Volume Vs. Average
53%
Short Selling HCW Biologics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for HCW Biologics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

HCWB Short Interest Over Time

HCWB Days to Cover Over Time

HCWB Percentage of Float Shorted Over Time

HCW Biologics Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202577,800 shares $329.87 thousand +49.9%4.3%0.1 $4.24
7/15/202551,900 shares $226.28 thousand -66.0%2.8%0.1 $4.36
6/30/2025152,600 shares $604.30 thousand +1,073.9%13.2%0.2 $3.96
6/15/202513,000 shares $70.85 thousand -68.1%1.1%0 $5.45
5/31/202540,700 shares $321.53 thousand -85.9%3.5%0.1 $7.90
5/15/2025288,400 shares $2.36 million +4,079.7%28.6%0.5 $8.20
4/30/20256,900 shares $55.61 thousand -22.5%1.0%0.5 $8.06
4/15/20258,900 shares $74.32 thousand -97.7%1.3%0.1 $8.35
3/31/2025390,900 shares $4.41 million -13.2%1.5%0.1 $11.28
3/15/2025450,200 shares $153.07 thousand -17.2%1.7%0.1 $0.34
2/28/2025543,700 shares $206.71 thousand -34.9%2.1%0.1 $0.38
2/15/2025835,500 shares $334.28 thousand +905.4%3.6%0.1 $0.40
1/31/202583,100 shares $23.12 thousand +50.8%0.4%0 $0.28
1/15/202555,100 shares $19.78 thousand -57.9%0.3%0 $0.36
12/31/2024131,000 shares $58.44 thousand -43.6%0.7%0 $0.45
12/15/2024232,100 shares $82.86 thousand +80.1%1.2%0 $0.36
11/30/2024128,900 shares $60.84 thousand -10.9%0.7%0 $0.47
11/15/2024144,700 shares $42.63 thousand +1,686.4%0.7%0 $0.29
10/31/20248,100 shares $3.49 thousand -67.5%0.0%0.3 $0.43
10/15/202424,900 shares $13.94 thousand -11.4%0.1%1.1 $0.56
9/30/202428,100 shares $15.16 thousand +119.5%0.2%1.4 $0.54
9/15/202412,800 shares $7.81 thousand +212.2%0.1%0.5 $0.61
8/31/20244,100 shares $1.89 thousand -65.0%0.0%0.2 $0.46
8/15/202411,700 shares $5.86 thousand +69.6%0.1%0.7 $0.50
7/31/20246,900 shares $4.17 thousand -4.2%0.0%0.3 $0.60
7/15/20247,200 shares $5.04 thousand -21.7%0.0%0.4 $0.70
6/30/20249,200 shares $5.95 thousand +70.4%0.1%0.4 $0.65
6/15/20245,400 shares $6.05 thousand +350.0%0.0%0.3 $1.12
5/31/20241,200 shares $1.31 thousand -7.7%0.0%0.1 $1.09
5/15/20241,300 shares $1.51 thousand -84.9%0.0%0.1 $1.16
4/30/20248,600 shares $12.04 thousand +13.2%0.1%0.5 $1.40
4/15/20247,600 shares $12.31 thousand -52.2%0.1%0.5 $1.62
3/31/202415,900 shares $27.83 thousand -27.7%0.1%1 $1.75
3/15/202422,000 shares $33.66 thousand -8.3%0.1%1.3 $1.53
2/29/202424,000 shares $35.28 thousand +445.5%0.2%1.7 $1.47
2/15/20244,400 shares $5.03 thousand +2.3%0.0%0.4 $1.14
1/31/20244,300 shares $4.95 thousand -39.4%0.0%0.2 $1.15
1/15/20247,100 shares $8.38 thousand -4.1%0.0%0.4 $1.18
12/31/20237,400 shares $9.07 thousand -38.8%0.0%0.4 $1.23
12/15/202312,100 shares $13.43 thousand -40.7%0.1%0.8 $1.11
Elon Musk’s New Technology (Ad)

Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.tc pixel

Get the full details on the AI company behind Musk’s next big move.
11/30/202320,400 shares $22.03 thousand -4.7%0.1%1.4 $1.08
11/15/202321,400 shares $19.69 thousand +170.9%0.1%1.6 $0.92
10/31/20237,900 shares $13.27 thousand -16.8%0.0%0.6 $1.68
10/15/20239,500 shares $17.29 thousand -10.4%0.1%1.3 $1.82
9/30/202310,600 shares $20.14 thousand -53.1%0.1%1.3 $1.90
9/15/202322,600 shares $45.43 thousand +5.6%0.1%2.5 $2.01
8/31/202321,400 shares $38.73 thousand -14.4%0.1%1.9 $1.81
8/15/202325,000 shares $52 thousand +7.8%0.1%1.4 $2.08
7/31/202323,200 shares $47.33 thousand -13.4%0.1%1.2 $2.04
7/15/202326,800 shares $56.82 thousand -23.7%0.2%1.4 $2.12
6/30/202335,100 shares $76.17 thousand +44.4%0.2%1.8 $2.17
6/15/202324,300 shares $51.76 thousand +86.9%0.1%1.2 $2.13
5/31/202313,000 shares $19.11 thousand -13.3%0.1%0.7 $1.47
5/15/202315,000 shares $22.05 thousand -45.3%0.1%1 $1.47
4/30/202327,400 shares $39.15 thousand -0.7%0.2%1.8 $1.43
4/15/202327,600 shares $41.40 thousand +10.8%0.2%1.5 $1.50
3/31/202324,900 shares $34.88 thousand +11.7%0.1%1.2 $1.40
3/15/202322,300 shares $30.11 thousand -20.6%0.1%1 $1.35
2/28/202328,100 shares $50.58 thousand +53.6%0.2%1.3 $1.80
2/15/202318,300 shares $34.59 thousand +140.8%0.1%0.8 $1.89
1/31/20237,600 shares $14.74 thousand -68.3%0.0%0.4 $1.94
1/15/202324,000 shares $51.60 thousand +31.2%0.2%1.2 $2.15
12/30/202218,300 shares $35.04 thousand +19.6%0.1%1.1 $1.91
12/15/202215,300 shares $30.60 thousand -41.6%0.1%0.8 $2.00
11/30/202226,200 shares $55.30 thousand +84.5%0.2%1.2 $2.11
11/15/202214,200 shares $31.24 thousand +23.5%0.1%0.6 $2.20
10/31/202211,500 shares $25.76 thousand -45.2%0.1%0.5 $2.24
10/15/202221,000 shares $46.83 thousand -58.7%0.1%0.9 $2.23
9/30/202250,900 shares $116.56 thousand +216.2%0.3%2.4 $2.29
9/15/202216,100 shares $39.28 thousand +35.3%0.1%0.9 $2.44
8/31/202211,900 shares $30.54 thousand -7.8%0.1%0.7 $2.57
8/15/202212,900 shares $28.77 thousand -30.7%0.1%1 $2.23
7/31/202218,600 shares $44.45 thousand +78.9%0.1%1.4 $2.39
7/15/202210,400 shares $24.23 thousand -38.1%0.1%0.8 $2.33
6/30/202216,800 shares $36.96 thousand +24.4%0.1%0.9 $2.20
6/15/202213,500 shares $32.27 thousand -9.4%0.1%0.5 $2.39
5/31/202214,900 shares $30.99 thousand -54.6%0.1%0.5 $2.08
5/15/202232,800 shares $64.62 thousand +9.0%0.2%1.1 $1.97
4/30/202230,100 shares $70.43 thousand -32.5%0.2%0.9 $2.34
4/15/202244,600 shares $121.31 thousand -3.5%0.3%0.9 $2.72
3/31/202246,200 shares $126.13 thousand -11.0%0.3%0.7 $2.73
3/15/202251,900 shares $106.91 thousand +19.6%0.4%0.6 $2.06
2/28/202243,400 shares $95.05 thousand -32.4%0.3%0.4 $2.19
2/15/202264,200 shares $150.87 thousand -18.5%0.5%0.6 $2.35
1/31/202278,800 shares $168.63 thousand -39.3%0.6%0.5 $2.14
1/15/2022129,800 shares $288.16 thousand +5.3%1.1%0 $2.22
12/31/2021123,300 shares $286.06 thousand +35.5%1.0%0 $2.32
12/15/202191,000 shares $249.34 thousand -3.1%0.7%0 $2.74
11/30/202193,900 shares $269.49 thousand -0.2%0.8%0 $2.87
11/15/202194,100 shares $278.54 thousand -39.5%0.8%0 $2.96
Elon Musk’s New Technology (Ad)

Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.tc pixel

Get the full details on the AI company behind Musk’s next big move.
10/29/2021155,400 shares $694.64 thousand +60.0%1.3%0.1 $4.47
10/15/202197,100 shares $254.40 thousand No Change0.8%0.6 $2.62
9/30/202197,100 shares $309.75 thousand +13.0%0.8%0.7 $3.19
9/15/202185,900 shares $325.56 thousand +30.2%0.7%0.6 $3.79
8/31/202166,000 shares $262.02 thousand +1,366.7%0.8%0.4 $3.97
8/13/20214,500 shares $23.04 thousand No Change0.1%0 $5.12

HCWB Short Interest - Frequently Asked Questions

What is HCW Biologics' current short interest?

Short interest is the volume of HCW Biologics shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 77,800 shares of HCWB short. 4.25% of HCW Biologics' shares are currently sold short. Learn More on HCW Biologics' current short interest.

What is a good short interest percentage for HCW Biologics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.25% of HCW Biologics' floating shares are currently sold short.

Is HCW Biologics' short interest increasing or decreasing?

HCW Biologics saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 77,800 shares, an increase of 49.9% from the previous total of 51,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is HCW Biologics' float size?

HCW Biologics currently has issued a total of 1,440,000 shares. Some of HCW Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. HCW Biologics currently has a public float of 1,830,000 shares.

How does HCW Biologics' short interest compare to its competitors?

4.25% of HCW Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to HCW Biologics: Dyadic International Inc. (0.37%), Biodexa Pharmaceuticals PLC Unsponsored ADR (0.49%), MIRA Pharmaceuticals, Inc. (3.01%), NanoViricides, Inc. (0.57%), Tenax Therapeutics, Inc. (9.22%), FibroBiologics Inc. (3.47%), Natural Alternatives International, Inc. (0.52%), Lisata Therapeutics, Inc. (0.70%), Promis Neurosciences (3.15%), CASI Pharmaceuticals Inc. (0.93%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short HCW Biologics stock?

Short selling HCWB is an investing strategy that aims to generate trading profit from HCW Biologics as its price is falling. HCWB shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against HCW Biologics?

A short squeeze for HCW Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HCWB, which in turn drives the price of the stock up even further.

How often is HCW Biologics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HCWB, twice per month. The most recent reporting period available is July, 31 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:HCWB) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Altucher: It Looks Like My Trump prediction is coming true
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...
Paradigm Press | Sponsoredtc pixel
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsoredtc pixel
Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
US attacks China, September 30?
The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...
Stansberry Research | Sponsoredtc pixel
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsoredtc pixel
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...
Investors Alley | Sponsoredtc pixel